Pathogenica, Inc. announced that teams from the University Medical Center Groningen (UMCG) and Amphia Hospital in the Netherlands are pioneering the use of the company’s HAI BioDetection Kit to prevent and control nosocomial infections in their facilities. With approx. 1,400 beds each, both Amphia and UMCG are among the largest hospitals in the world. Pathogenica’s […]

bioMérieux, a world leader in the field of in vitro diagnostics, is pleased to announce it has joined with Ultimate Labs, a leader in the safe production and quality control of food, drugs, and medical devices, to provide the industry with VITEK® MS – the most rapid mass spectrometry method available to detect microbial pathogens […]

ALISO VIEJO, CA, – GE Healthcare today announced the introduction by Clarient Diagnostic Services, a GE Healthcare Company, of the first lab developed test using MultiOmyx™, a ground-breaking new pathology platform which uses proprietary methodology to assess multiple proteins from a single tissue section at a single-cell level. This test, now available, offers an aid […]

RICHMOND, VA — AIBioTech has reached the milestone of 20,000 DNA samples sequenced on its Ion Torrent Personal Genome Machines™ (PGMÔ) by Life Technologies. As an early adapter of this cutting edge technology, AIBioTech is one of the first companies to apply the Life Technologies Ion Torrent sequencing technology to the CLIA laboratory market place. […]

Toronto, Canada,- Axela Inc. announced today it has entered into a development agreement to integrate Thermal Gradient’s rapid PCR technology into Axela’s Flow-Thru Chip® automated workflow. Thermal Gradient’s sample preparation and amplification technology will initially be added to Axela’s patent pending approach for the capture and quantification of targeted nucleic acids. Currently optimized for formalin […]

Leica Biosystems announced that it has acquired Kreatech Diagnostics, a privately-held provider of DNA fluorescent in-situ hybridization (FISH) probes and target labeling reagents for microarrays. “We are very pleased with the acquisition of Kreatech, its extensive portfolio and development expertise. This will allow Leica Biosystems to better serve our cytogenetics and anatomic pathology customers. It […]

Franklin Lakes, NJ – BD (Becton, Dickinson and Company) (NYSE:BDX), a leading global medical technology company, today announced the appointment of Christopher Reidy as Chief Financial Officer and Executive Vice President of Administration, effective July 15, 2013. Mr. Reidy will report to Vincent A. Forlenza, Chairman, Chief Executive Officer and President. Mr. Reidy, 55, will […]

UCART19 is a revolutionary engineered T-cell product that leverages Cellectis’ core technologies in genome engineering. This standardized “off-the-shelf” therapy product is designed with a “chimeric antigen receptor” (CAR) to target and kill the most common types of acute and chronic leukemia and are engineered with Cellectis’ nucleases enabling the use of non-patient derived (allogeneic) T-cells. […]

INDIANAPOLIS, — Roche (SIX: RO, ROG; OTCQX: RHHBY) announced today that its U.S. Diagnostics unit was ranked number one in overall service performance by clinical laboratories in the 2013 ServiceTrak™ Clinical Report. The report was issued by IMV Ltd, an independent firm that produces an annual series of proprietary reports derived from extensive phone surveys […]